ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.34X leverage
Eris Lifesciences live price: ₹1321.1. It opened at ₹1,342 vs previous close ₹1,352; intraday high/low: ₹1,353/₹1,310. The 50 & 200 DMA stand at ₹1,412.31/₹1,499.74.
Eris Lifesciences Performance
- Low
- ₹1,310
- High
- ₹1,353
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,342
- Previous Close₹1,352
- Volume93,073
- 50 DMA₹1,412.31
- 100 DMA₹1,472.55
- 200 DMA₹1,499.74
Investment Returns
- Over 1 Month -6.6%
- Over 3 Month -15.97%
- Over 6 Month -21.17%
- Over 1 Year + 5.29%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.4
- PEG Ratio
- 1.4
- Market Cap Cr
- 18,303
- P/B Ratio
- 5.7
- Average True Range
- 40.17
- EPS
- 32.09
- Dividend Yield
- 0
- MACD Signal
- -21.68
- RSI
- 38.31
- MFI
- 51.43
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,321.10
-30.5
(-2.26%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,364.10
- 50 Day
- ₹1,412.31
- 100 Day
- ₹1,472.55
- 200 Day
- ₹1,499.74
Resistance and Support
1328.03
- R3 1,389.07
- R2 1,371.03
- R1 1,346.07
- S1 1,303.07
- S2 1,285.03
- S3 1,260.07
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,321 As on 15 March, 2026 | 22:50
The Market Cap of Eris Lifesciences is ₹18302.9 Cr As on 15 March, 2026 | 22:50
The P/E ratio of Eris Lifesciences is 42.4 As on 15 March, 2026 | 22:50
The PB ratio of Eris Lifesciences is 5.7 As on 15 March, 2026 | 22:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.